What is the most appropriate management for a 32-year-old woman with two large intramural uterine leiomyomas who wishes to preserve fertility and is anemic due to heavy painful menstrual bleeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Large Intramural Fibroids with Fertility Preservation

For a 32-year-old woman with large intramural fibroids desiring future pregnancy and experiencing anemia from heavy menstrual bleeding, laparoscopic or open myomectomy is the most appropriate definitive management, preceded by a short course of medical therapy to correct anemia and potentially reduce fibroid size preoperatively. 1

Immediate Management: Address Anemia First

Before pursuing definitive surgical treatment, the patient's anemia must be corrected:

  • Iron supplementation is essential to restore hemoglobin levels
  • Short-term medical management (2-3 months) can simultaneously reduce bleeding and shrink fibroids to optimize surgical conditions

Medical Therapy Options for Preoperative Preparation

GnRH antagonists (relugolix combination therapy) or GnRH agonists (leuprolide) are the most effective preoperative medical options 1:

  • Both significantly reduce tumor volume and bleeding symptoms
  • GnRH antagonists with add-back estrogen/progestin therapy minimize hypoestrogenic side effects (hot flashes, bone loss) 1
  • These agents are specifically used for short courses to decrease fibroid size in preparation for surgery 1
  • Critical caveat: Fertility is suppressed during treatment, and symptoms rapidly recur after cessation, making these unsuitable as long-term solutions 1

Alternative bridging options while correcting anemia:

  • Combined oral contraceptives or levonorgestrel IUD for bleeding control 1
  • Tranexamic acid as a nonhormonal option 1

Definitive Treatment: Myomectomy

Why Myomectomy is the Optimal Choice

Laparoscopic or open myomectomy is specifically indicated for intramural fibroids in patients desiring fertility preservation 1. The 2024 ACR Appropriateness Criteria explicitly state this is "usually appropriate" for reproductive-age patients with symptomatic fibroids desiring pregnancy 1.

Surgical Approach Selection

Open myomectomy is preferred when dealing with:

  • Multiple fibroids (this patient has 2 large fibroids)
  • Very large uteri 1

Laparoscopic approach offers advantages when technically feasible:

  • Shorter hospital stays
  • Faster return to usual activities
  • Similar fertility outcomes to open approach 1
  • Robotic-assisted laparoscopy shows similar outcomes to traditional laparoscopy 1

Expected Outcomes

Quality of life improvements: Both laparoscopic and open myomectomy provide sustained improvement in quality of life for up to 10 years 1

Fertility outcomes: Large prospective registries demonstrate no significant difference in fertility outcomes among hysteroscopic, laparoscopic, and open myomectomy 1. However, realistic counseling is essential:

  • Less than half of patients trying to conceive achieve pregnancy after myomectomy at 3 years follow-up
  • Of those pregnancies, less than half result in live birth 1
  • Important warning: Case reports associate myomectomy with uterine rupture during subsequent pregnancy 1

Why Other Options Are Less Appropriate

Uterine Artery Embolization (UAE)

While UAE is listed as "usually appropriate" in guidelines 1, it has concerning fertility implications:

  • Pregnancy rates after UAE are lower than desired (69% pregnancy rate, but only 50% live birth rate) 1
  • 34% abortion rate 1
  • For a 32-year-old actively desiring pregnancy, myomectomy provides better fertility preservation

MR-Guided Focused Ultrasound (MRgFUS)

  • High reintervention rate (30-33% at 2 years) 1
  • Less effective symptom control compared to UAE 1
  • Insufficient data on fertility outcomes
  • Not optimal for large intramural fibroids requiring definitive treatment

Medical Management Alone

  • Cannot serve as definitive therapy because symptoms rapidly recur after cessation 1
  • Fertility is suppressed during treatment 1
  • Best used as preoperative preparation, not standalone treatment

Clinical Algorithm

  1. Initiate iron supplementation immediately to correct anemia
  2. Start GnRH antagonist combination therapy (relugolix with estrogen/progestin) for 2-3 months to:
    • Reduce bleeding and improve hemoglobin
    • Shrink fibroid size for easier surgical removal
    • Minimize intraoperative blood loss
  3. Perform myomectomy (open vs. laparoscopic based on fibroid characteristics and surgeon expertise)
  4. Counsel patient about:
    • Realistic fertility expectations post-myomectomy
    • Risk of uterine rupture in future pregnancy
    • Need for cesarean delivery consideration
    • Possibility of fibroid recurrence

Critical Pitfalls to Avoid

  • Do not pursue long-term medical management alone in a patient desiring pregnancy—this delays definitive treatment and fertility is suppressed during therapy
  • Do not choose UAE as first-line in a young patient actively desiring pregnancy when myomectomy is feasible
  • Do not perform surgery without correcting anemia first—this increases perioperative risks
  • Do not use GnRH agonists without add-back therapy if using for more than a few months—bone loss and hypoestrogenic symptoms are significant

References

Guideline

acr appropriateness criteria® management of uterine fibroids: 2023 update.

Journal of the American College of Radiology, 2024

Related Questions

In a 60-year-old woman with multiple uterine fibroids who complains of cramping, what is the appropriate treatment approach?
What is the most effective therapy for a 52-year-old woman who had a hysterectomy for uterine fibroids and now experiences frequent hot flashes lasting 3–5 minutes, occurring 5–10 times daily for the past 5 months?
For a 41-year-old woman with type 2 diabetes mellitus, chronic iron‑deficiency anemia, dyslipidemia, anxiety, dysmenorrhea, and abnormal uterine bleeding due to intramural uterine fibroids, who is currently on metformin, atorvastatin, Depo‑Provera (depot medroxyprogesterone acetate), and iron supplementation, what additional management steps should be taken?
In a 54-year-old asymptomatic woman with a 5‑cm cervical leiomyoma (fibroid) that appears possibly cystic on MRI and measures 5.2 cm on repeat surveillance ultrasound, what is the recommended management?
What is the appropriate work‑up and management for a 33‑year‑old woman with heavy menstrual bleeding, pelvic pain, a prior dermoid cyst, and ultrasound showing a 1.9 cm submucosal myometrial lesion and a 2.2 cm left ovarian complex cyst?
Can hepatitis B virus be transmitted during massage therapy?
After open reduction internal fixation (ORIF) of a patella fracture, when and how should weight bearing be initiated?
How should I stepwise manage a patient with infected stasis dermatitis and lymphedema?
Can you interpret the knee imaging findings and recommend management for an 82‑year‑old patient with knee pain, mild‑to‑moderate degenerative changes and severe patellofemoral joint space narrowing?
Can a bout of sneezing cause aspiration pneumonia?
How does the anti‑inflammatory potency of dexamethasone ophthalmic 0.1% (Maxidex) compare to prednisolone acetate 1% eye drops?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.